-
Adverum Biotechnologies, Inc.,
formerly known as
Avalanche Biotechnologies, is a
publicly traded clinical stage gene
therapy company located in Redwood...
-
soroparvovec (Ixo-vec, also
known as ADVM-022), is a gene
therapy developed by
Adverum Biotechnologies for wet age-related
macular degeneration. It is delivered...
-
including Oculex, Peak Surgical,
Optimedica Corporation, MacuSight, and
Adverum Biotechnologies. In addition, he
serves as a
trustee of
Brown University...
- degeneration. In 2011 it was
licensed to
Avalanche Biotechnologies Inc., (now
Adverum Biotechnologies),
which used the
technology to
raise ~$300 Million. Rakoczy...
- age-related
macular degeneration (nAMD), key
intravitreal agents include Adverum Biotechnologies’
ixoberogene soroparvovec (Ixo-vec) and 4D
Molecular Therapeutics’...
- 102394. doi:10.1016/j.eclinm.2023.102394. PMC 10751837. PMID 38152412. "
Adverum Biotechnologies announces FDA
Regenerative Medicine Advanced Therapy designation...
